Annual CFF
-$3.22 M
-$98.55 M-103.37%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual cash flow from financing activities is -$3.22 million, with the most recent change of -$98.55 million (-103.37%) on December 31, 2023.
- During the last 3 years, DNA annual CFF has fallen by -$93.53 million (-103.56%).
- DNA annual CFF is now -100.21% below its all-time high of $1.53 billion, reached on December 31, 2021.
Performance
DNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$465.00 K
-$239.00 K-105.75%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly cash flow from financing activities is -$465.00 thousand, with the most recent change of -$239.00 thousand (-105.75%) on September 30, 2024.
- Over the past year, DNA quarterly CFF has increased by +$167.00 thousand (+26.42%).
- DNA quarterly CFF is now -100.03% below its all-time high of $1.55 billion, reached on September 30, 2021.
Performance
DNA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$2.17 M
-$150.00 K-7.43%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM cash flow from financing activities is -$2.17 million, with the most recent change of -$150.00 thousand (-7.43%) on September 30, 2024.
- Over the past year, DNA TTM CFF has increased by +$1.05 million (+32.59%).
- DNA TTM CFF is now -100.14% below its all-time high of $1.55 billion, reached on September 30, 2021.
Performance
DNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DNA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -103.4% | +26.4% | +32.6% |
| 3 y3 years | -103.6% | +26.4% | +32.6% |
| 5 y5 years | -100.8% | - | - |
DNA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.2% | at low | -100.5% | +95.8% | -100.1% | +83.9% |
| 5 y | 5-year | -100.2% | at low | -100.0% | +95.8% | -100.1% | +83.9% |
| alltime | all time | -100.2% | at low | -100.0% | +95.8% | -100.1% | +83.9% |
Ginkgo Bioworks Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$465.00 K(+105.8%) | -$2.17 M(+7.4%) |
| Jun 2024 | - | -$226.00 K(-73.3%) | -$2.02 M(-36.4%) |
| Mar 2024 | - | -$845.00 K(+33.7%) | -$3.17 M(-1.3%) |
| Dec 2023 | -$3.22 M(-103.4%) | -$632.00 K(+100.6%) | -$3.22 M(-103.4%) |
| Sep 2023 | - | -$315.00 K(-77.2%) | $95.18 M(+0.1%) |
| Jun 2023 | - | -$1.38 M(+55.5%) | $95.10 M(-0.6%) |
| Mar 2023 | - | -$888.00 K(-100.9%) | $95.64 M(+0.3%) |
| Dec 2022 | $95.34 M | $97.76 M(<-9900.0%) | $95.34 M(-807.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$391.00 K(-53.6%) | -$13.47 M(-100.9%) |
| Jun 2022 | - | -$843.00 K(-29.3%) | $1.53 B(+0.1%) |
| Mar 2022 | - | -$1.19 M(-89.2%) | $1.53 B(-0.0%) |
| Dec 2021 | $1.53 B(+1598.6%) | -$11.04 M(-100.7%) | $1.53 B(-0.7%) |
| Sep 2021 | - | $1.55 B(<-9900.0%) | $1.55 B(<-9900.0%) |
| Jun 2021 | - | -$2.12 M(+390.3%) | -$2.56 M(+490.3%) |
| Mar 2021 | - | -$433.00 K | -$433.00 K |
| Dec 2020 | $90.32 M(-78.0%) | - | - |
| Dec 2019 | $410.38 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual CFF year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly CFF year-on-year change?
- What is Ginkgo Bioworks Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM CFF year-on-year change?
What is Ginkgo Bioworks Holdings annual cash flow from financing activities?
The current annual CFF of DNA is -$3.22 M
What is the all time high annual CFF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual cash flow from financing activities is $1.53 B
What is Ginkgo Bioworks Holdings annual CFF year-on-year change?
Over the past year, DNA annual cash flow from financing activities has changed by -$98.55 M (-103.37%)
What is Ginkgo Bioworks Holdings quarterly cash flow from financing activities?
The current quarterly CFF of DNA is -$465.00 K
What is the all time high quarterly CFF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly cash flow from financing activities is $1.55 B
What is Ginkgo Bioworks Holdings quarterly CFF year-on-year change?
Over the past year, DNA quarterly cash flow from financing activities has changed by +$167.00 K (+26.42%)
What is Ginkgo Bioworks Holdings TTM cash flow from financing activities?
The current TTM CFF of DNA is -$2.17 M
What is the all time high TTM CFF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM cash flow from financing activities is $1.55 B
What is Ginkgo Bioworks Holdings TTM CFF year-on-year change?
Over the past year, DNA TTM cash flow from financing activities has changed by +$1.05 M (+32.59%)